Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

CRISPR Therapeutics (NASDAQ:CRSP) gains visibility as biotechnology activity aligns with broader movements across the Nasdaq ...

A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two ...

To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...

UC Davis researchers engineered wheat that encourages soil bacteria to convert atmospheric nitrogen into plant-usable ...

When UC Berkeley biochemist Jennifer Doudna first began studying how bacteria fight virus infections, she had no idea it ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Cardiologist and Men's Health advisory board member Christopher Kelly, MD, says this treatment is "approaching magic" for ...

Researchers used CRISPR to change the number of chromosomes in Arabidopsis by fusing chromosome arms, reducing the genome ...

The launch of BIRSA 101 marks a major breakthrough in CRISPR gene-editing technology, positioning India to deliver affordable ...

America's next wave of scientific talent may come from Lambert High School, where students used CRISPR to develop a promising ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...